# Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation

> **NCT01607359** · — · WITHDRAWN · sponsor: **Corewell Health East**

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01607359
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-05
- **Primary completion:** 2012-10
- **Final completion:** 2017-04-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn: It was decided not to proceed with the study at this time.
- **Last updated:** 2023-05-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607359, "Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01607359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*